Woost, P. G., William, B. M., Cooper, B. W., Ueda Oshima, M., Otegbeye, F., De Lima, M. J., . . . Jacobberger, J. W. (2024). Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies. Cytometry. Part B, 106(1), 11-24. https://doi.org/10.1002/cyto.b.22158
Chicago Style (17th ed.) CitationWoost, Philip G., et al. "Flow Cytometry of DNMT1 as a Biomarker of Hypomethylating Therapies." Cytometry. Part B 106, no. 1 (2024): 11-24. https://doi.org/10.1002/cyto.b.22158.
MLA (8th ed.) CitationWoost, Philip G., et al. "Flow Cytometry of DNMT1 as a Biomarker of Hypomethylating Therapies." Cytometry. Part B, vol. 106, no. 1, 2024, pp. 11-24, https://doi.org/10.1002/cyto.b.22158.
Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.
Visit our Citation Styles guide for help on properly citing sources.